U.S. Arteriovenous Fistula Devices Market Size, Share & Trends Analysis Report By Type (AVF Creation Devices, AVF Monitoring Devices, AVF Maintenance Devices), By End-use (Hospitals, Ambulatory Surgical Centers, Dialysis Centers), And Segment Forecasts, 2

U.S. Arteriovenous Fistula Devices Market Summary

The U.S. arteriovenous fistula devices market size was estimated at USD 111.0 million in 2024 and is projected to reach USD 120.0 million by 2033, growing at a CAGR of 0.9% from 2025 to 2033. The growth is attributed to several factors, including the increasing prevalence rate of End-stage Renal Disease (ESRD) and the resulting rise in the number of patients requiring hemodialysis.

The advanced healthcare infrastructure, a high incidence of diabetes & hypertension, and widespread awareness initiatives in the country are expected to drive the market growth. According to 2023 estimates by the Centers for Disease Control and Prevention (CDC), approximately 14% of adults in the U.S. are affected by chronic kidney disease (CKD). Furthermore, the American Kidney Fund reports that approximately 815,000 Americans are currently living with kidney failure, with nearly 555,000 of them undergoing dialysis, highlighting the widespread need for effective treatment solutions.

Due to the critical shortage of kidney donors, the increasing dependence on dialysis underscores the essential role of AVF devices in managing ESRD. The escalating rate of kidney disease is also driving the demand for more advanced and innovative AVF solutions. AV fistulas are preferred for long-term vascular access because of their durability, lower infection rates, and reduced complication risk compared to other access types. These factors are propelling the growth of AVF devices in the U.S.

Two other types of vascular access for hemodialysis, arteriovenous graft (AVG) and central venous catheter (CVC), are the primary substitutes for an arteriovenous fistula. The choice of access has significant clinical and economic implications, directly impacting market dynamics. While AVFs are considered the gold standard due to lower infection rates and better longevity, their long maturation time and high primary failure rate make substitutes necessary.

U.S. Arteriovenous Fistula Devices Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. arteriovenous fistula devices market report based on type and end-use.

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• AVF Creation Devices
• Surgical Instruments
• Vascular Grafts
• Angioplasty Balloons
• Others
• AVF Monitoring Devices
• Doppler Ultrasound
• Pressure Monitoring Systems
• Others
• AVF Maintenance Devices
• Central Venous Catheters
• Stents
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers
• Dialysis Centers

Please note The report will be delivered in 2-3 business days upon order notification. Show more